Trial Profile
Phase I and Pharmacokinetic Study of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Mitomycin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 11 Sep 2005 New trial record.